Drugs in Dev.
Rare Diseases and Disorders
Preclinical
Switzerland 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : $3.8 million
Deal Type : Financing
Release Therapeutics Secures CHF 3.3 Million in Seed Funding
Details : The financing is intended to support the initial preclinical stages to advance the clinical development of the company's lead product for treating patients with metachromatic leukodystrophy.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 06, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : $3.8 million
Deal Type : Financing
